Registration Now Open: 2 Day Human Factors and Usability Engineering in Development of Drug Delivery Devices Training Course (ONLINE EVENT: May 13-14, 2025)
March 18, 2025 09:44 ET
|
Research and Markets
Dublin, March 18, 2025 (GLOBE NEWSWIRE) -- The "Human Factors and Usability Engineering in the Development of Drug Delivery Products Training Course" has been added to ResearchAndMarkets.com's...
Opportunities in the Human Liver Model Market 2025-2030 - Integrating Hybrid and In Silico Models Revolutionizing Drug Development with Faster and More Accurate Insights
March 17, 2025 08:39 ET
|
Research and Markets
Dublin, March 17, 2025 (GLOBE NEWSWIRE) -- The "Human Liver Model Market by Model Type (2D Models, 3D Models, Ex Vivo Models), Cell Source (Immortalized Liver Cell Lines, Primary Human Hepatocytes,...
Middle East and North Africa Clinical Trial Infrastructure Market Report 2025: Regulatory Reforms Enabling Faster Approvals, Public-Private Partnerships Boosting Research Capacity
March 17, 2025 07:50 ET
|
Research and Markets
Dublin, March 17, 2025 (GLOBE NEWSWIRE) -- The "Middle East and North Africa Clinical Trial Infrastructure Market" report has been added to ResearchAndMarkets.com's offering.The Middle East and...
Pharmacovigilance Market Forecast to Surge to $24.76 Billion by 2030, Creating Lucrative Opportunities for Digital Transformation in Drug Safety
March 13, 2025 07:43 ET
|
Research and Markets
Dublin, March 13, 2025 (GLOBE NEWSWIRE) -- The "Pharmacovigilance Market by Type (Cohort Event Monitoring, EHR Mining, Intensified ADR Reporting), Product Life Cycle (Phase I, Phase II, Phase III),...
Bispecific Antibody Market Opportunity, Drug Dosage, Patent, Price, Sales & Clinical Trials Insight 2030: New Report Highlights 600+ Bispecific Antibodies in Clinical Trials Worldwide
March 12, 2025 08:48 ET
|
Research and Markets
Dublin, March 12, 2025 (GLOBE NEWSWIRE) -- The "Bispecific Antibody Market Opportunity, Drug Dosage, Patent, Price, Sales & Clinical Trials Insight 2030" report has been added to ...
Clinical Trials Market Forecast Report 2025: A $99.25 Billion Industry by 2033, Driven by Acceptance of Decentralized Experiments, Shift Towards Personalized Medicine, Demand for Effective Treatments
March 10, 2025 10:18 ET
|
Research and Markets
Dublin, March 10, 2025 (GLOBE NEWSWIRE) -- The "Clinical Trials Market Forecast Report by Phase, Indication, Study Material, Country and Company 2025-2033" report has been added to ...
Generative AI in Drug Discovery and Development Process Course: FDA Embraces Generative AI to Propel Drug Discovery and Development Forward (ONLINE EVENT: April 2, 2025 & ON-DEMAND)
March 10, 2025 08:30 ET
|
Research and Markets
Dublin, March 10, 2025 (GLOBE NEWSWIRE) -- The "Generative AI in Drug Discovery" training has been added to ResearchAndMarkets.com's offering. The US FDA's encouragement of AI technology in...
National Citizen Scientist Awards Honor Outstanding Clinical Trial Volunteers for Their Role in Advancing Research
February 28, 2025 09:00 ET
|
Global Alzheimer’s Platform Foundation®
Washington D.C., Feb. 28, 2025 (GLOBE NEWSWIRE) -- The Global Alzheimer’s Platform Foundation® (GAP) proudly announced the 2024 National Citizen Scientist Awards® elevated honorees at their 2025...
Novartis oral Fabhalta® (iptacopan) receives positive CHMP opinion for the treatment of adults living with C3 glomerulopathy (C3G)
February 28, 2025 07:39 ET
|
Novartis Pharma AG
If approved, Fabhalta® will be the only medicine indicated to selectively target the underlying cause of C3G1, an ultra-rare, progressive kidney disease with no currently approved treatments2-5 ...
Robert Califf, MD, MAAC, to Deliver Keynote Address at 2025 MDA Clinical & Scientific Conference
February 27, 2025 09:00 ET
|
Muscular Dystrophy Association
New York, Feb. 27, 2025 (GLOBE NEWSWIRE) -- The Muscular Dystrophy Association (MDA) announced today that Robert Califf, MD, MAAC, former Commissioner of the U.S. Food and Drug Administration and...